SCHEMBL5583548

SCHEMBL5583548

COc1cccc(-c2cccc3c2O[CH]C3)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.48
HTR7 P34969 1/20 0.48
TDO2 P48775 1/20 0.43
PPARG P37231 1/20 0.42
PPARD Q03181 1/20 0.42
PPARA Q07869 1/20 0.42
MEN1 O00255 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CD274 Q9NZQ7 1/20 0.42
NOTUM Q6P988 1/20 0.42
GSK3B P49841 1/20 0.41
CYP1A1 P04798 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2E1 P05181 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C8 P10632 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2A6 P11509 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27705416 0.87 HTR1A (0.50) HTR1AHTR7TDO2PPARGPPARD
SCHEMBL27723675 0.83 KDM1A (0.41) HTR1AHTR7TDO2PPARGPPARD
SCHEMBL27703110 0.80 NPSR1 (0.45) HTR1AHTR7TDO2MEN1MAPT
SCHEMBL5583652 0.80 ENPP3 (0.40) SMN1; SMN2GSK3BDYRK1ACLK4
SCHEMBL5586538 0.80 CYP3A4 (0.49) MEN1MAPTKMT2ASMN1; SMN2CYP1A1
SCHEMBL5586539 0.77 HTR1A (0.44) HTR1AHTR7MEN1MAPTKMT2A
SCHEMBL4597055 0.74 HTR1A (0.49) HTR1AHTR7TDO2CD274NOTUM
SCHEMBL4761887 0.73 HTR1A (0.48) HTR1AHTR7MAPTNOTUMALDH1A1
SCHEMBL4597054 0.73 HTR1A (0.48) HTR1AHTR7TDO2CD274NOTUM
SCHEMBL2020140 0.73 ABL1 (0.59) TDO2SMN1; SMN2CYP1A1CYP1A2CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2007509174-A 2007-04-12 JP claimed
EP-1675840-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS Wyeth a Corporation of the State of Delaware (US) 2006-07-05 EP claimed
WO-2005044812-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS WYETH A CORPORATION OF THE STATE OF DELAWARE (US) 2005-05-19 WO claimed